In clear cell renal cell carcinoma, SIK2 downregulation promotes tumor progression by inhibiting autophagy, depending on FTO/IGF2BP2-m6A axis-mediated SIK2 mRNA stabilization [84]. Here, IGF2BP2 is linked to neoplasm.